» Articles » PMID: 11724966

Specific Interference with Gene Expression Induced by Long, Double-stranded RNA in Mouse Embryonal Teratocarcinoma Cell Lines

Overview
Specialty Science
Date 2001 Nov 29
PMID 11724966
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

In eukaryotes, double-stranded (ds) RNA induces sequence-specific inhibition of gene expression, referred to as RNA interference (RNAi). In invertebrates, RNAi can be triggered effectively by either long dsRNAs or 21- to 23-nt-long short interfering (si) duplex RNAs, acting as effectors of RNAi. siRNAs recently have been shown to act as potent inducers of RNAi in cultured mammalian cells. However, studies of RNAi activated by long dsRNA are impeded by its nonspecific effects, mediated by dsRNA-dependent protein kinase PKR and RNase L. Here, we report that the RNAi response can be induced effectively by long dsRNA in nondifferentiated mouse cells grown in culture. Transfection of dsRNA into embryonal carcinoma (EC) P19 and F9 cells results in a sequence-specific decrease in the level of proteins expressed from either exogenous or endogenous genes. dsRNA-mediated inhibition of the reporter gene also occurs in mouse embryonic stem cells. The RNAi effect is mediated by siRNAs, which are generated by cleavage of dsRNA by the RNaseIII-like enzyme, Dicer. We demonstrate that extracts prepared from EC cells catalyze processing of dsRNA into approximately 23-nt fragments and that Dicer localizes to the cytoplasm of EC and HeLa cells.

Citing Articles

The subcellular topology of the RNAi machinery ismultifaceted and reveals adherens junctions as anepithelial hub.

Nair-Menon J, Kingsley C, Mesnaoui H, Lin P, Wilson K, Rohrer B Res Sq. 2025; .

PMID: 40034449 PMC: 11875308. DOI: 10.21203/rs.3.rs-5837046/v1.


Challenges and Opportunities Arising from Host- Interactions to Outline Novel and Sustainable Control Strategies: The Key Role of RNA Interference.

Spada M, Pugliesi C, Fambrini M, Pecchia S Int J Mol Sci. 2024; 25(12).

PMID: 38928507 PMC: 11203536. DOI: 10.3390/ijms25126798.


SARS-CoV-2 RNAs are processed into 22-nt vsRNAs in Vero cells.

Liu Y, Rao J, Mi Y, Chen L, Feng L, Li Q Front Immunol. 2022; 13:1008084.

PMID: 36389816 PMC: 9650353. DOI: 10.3389/fimmu.2022.1008084.


Discovery and Use of Long dsRNA Mediated RNA Interference to Stimulate Antiviral Protection in Interferon Competent Mammalian Cells.

Semple S, Au S, Jacob R, Mossman K, DeWitte-Orr S Front Immunol. 2022; 13:859749.

PMID: 35603190 PMC: 9120774. DOI: 10.3389/fimmu.2022.859749.


Exploring clinical implications and role of non-coding RNAs in lung carcinogenesis.

Roy S, Ganguly N, Banerjee S Mol Biol Rep. 2022; 49(7):6871-6883.

PMID: 35076850 DOI: 10.1007/s11033-022-07159-w.


References
1.
Burke D, Graham C, Lehman J . Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro. Cell. 1978; 13(2):243-8. DOI: 10.1016/0092-8674(78)90193-9. View

2.
Parrish S, Fleenor J, Xu S, Mello C, Fire A . Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference. Mol Cell. 2000; 6(5):1077-87. DOI: 10.1016/s1097-2765(00)00106-4. View

3.
Krause D, Silverman R, Jacobsen H, Leisy S, Dieffenbach C, Friedman R . Regulation of ppp(A2'p)nA-dependent RNase levels during interferon treatment and cell differentiation. Eur J Biochem. 1985; 146(3):611-8. DOI: 10.1111/j.1432-1033.1985.tb08695.x. View

4.
Francis M, Lehman J . Control of beta-interferon expression in murine embryonal carcinoma F9 cells. Mol Cell Biol. 1989; 9(8):3553-6. PMC: 362405. DOI: 10.1128/mcb.9.8.3553-3556.1989. View

5.
Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T, Taniguchi T . Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell. 1990; 63(2):303-12. DOI: 10.1016/0092-8674(90)90163-9. View